Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Cancer|May 13, 2017
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and AdolescentsFrédéric Millot, Christelle Dupraz, Joelle Guilhot, et al.
Haematologica|March 23, 2010
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemiaAnne M Dickinson, Kim F Pearce, Jean Norden, et al.
Haematologica|October 23, 2025
Children with chronic phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CMLFrédéric Millot, Joe De Keizer, Markus Metzler, et al.
Bone Marrow Transplantation|April 2, 2020
Curability and transferability of atopy with allogeneic hematopoietic cell transplantationSarah Whiteside, Alex Chin, Gaurav Tripathi, et al.
Pediatrics|March 4, 2009
Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiencyWaseem Qasim, Marina Cavazzana-Calvo, E Graham Davies, et al.
Bone Marrow Transplantation|November 5, 2023
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trialKarl-Walter Sykora, Rita Beier, Ansgar Schulz, et al.
British Journal of Haematology|September 30, 2025
Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working PartyNimrod Buchbinder, Victor Michel, Arnaud Dalissier, et al.
Leukemia|January 27, 2023
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendationsStephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, et al.
Bone Marrow Transplantation|March 24, 2020
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kalwak, Monika Mielcarek, Katharine Patrick, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Pageof 13